Association between Tumorigenic Potential and the Fate of Cancer Cells in a Syngeneic Melanoma Model

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Krelin, Yakov ^a,c   Berkovich, Liron ^a,c   Amit, Moran ^b,c   Gil, Ziv ^a,b,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER MODEL; CARCINOGENICITY; CELL ACTIVITY; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL FATE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN K1735 16; CELL STRAIN K1735 M4; CELL SUSPENSION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE TECHNIQUE; GROWTH RATE; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MOUSE; NONHUMAN; SCID MOUSE; SERUM; SPHEROID CELL; ANIMAL; CANCER STEM CELL; CANCER TRANSPLANTATION; DISEASE MODEL; DRUG SCREENING; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOPHENOTYPING; ISOGRAFT; METABOLISM; MULTICELLULAR SPHEROID; TUMOR CELL CULTURE; TUMOR CELL LINE; TUMOR REGRESSION;

ANIMALIA; MUS;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; IMMUNOPHENOTYPING; MELANOMA; MICE; MICE, SCID; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; SPHEROIDS, CELLULAR; TRANSPLANTATION, ISOGENEIC; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 84876532839     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062124     Document Type: Article

References (51)

1. Shackleton M, Quintana E, Fearon ER, Morrison SJ, (2009) Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138: 822-829.
2. Kleinsmith LJ, Pierce GB Jr, (1964) Multipotentiality of Single Embryonal Carcinoma Cells. Cancer Res 24: 1544-1551.
3. Illmensee K, Mintz B, (1976) Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc Natl Acad Sci U S A 73: 549-553.
4. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, et al. (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648.
5. Bonnet D, Dick JE, (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737.
6. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
7. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
8. O'Brien CA, Pollett A, Gallinger S, Dick JE, (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110.
9. Al-Hajj M, (2007) Cancer stem cells and oncology therapeutics. Curr Opin Oncol 19: 61-64.
10. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
11. Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, et al. (2008) Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 105: 13427-13432.
12. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, et al. (2008) Identification of cells initiating human melanomas. Nature 451: 345-349.
13. Monzani E, Facchetti F, Galmozzi E, Corsini E, Benetti A, et al. (2007) Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 43: 935-946.
14. Yoon CH, Kim MJ, Kim RK, Lim EJ, Choi KS, et al. (2012). c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells. Oncogene.
15. Sutherland RM, MacDonald HR, Howell RL, (1977) Multicellular spheroids: a new model target for in vitro studies of immunity to solid tumor allografts. J Natl Cancer Inst 58: 1849-1853.
16. Kunz-Schughart LA, (1999) Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor. Cell Biol Int 23: 157-161.
17. Clevers H, (2011) The cancer stem cell: premises, promises and challenges. Nat Med 17: 313-319.
18. Freedman VH, Shin SI, (1974) Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3: 355-359.
19. Cremona CA, Lloyd AC, (2009) Loss of anchorage in checkpoint-deficient cells increases genomic instability and promotes oncogenic transformation. J Cell Sci 122: 3272-3281.
20. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
21. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, et al. (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65: 9328-9337.
22. Harrell MI, Iritani BM, Ruddell A, (2007) Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 170: 774-786.
23. Lamerato-Kozicki AR, Helm KM, Jubala CM, Cutter GC, Modiano JF, (2006) Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation. Exp Hematol 34: 870-878.
24. Rota LM, Lazzarino DA, Ziegler AN, LeRoith D, Wood TL, (2012) Determining mammosphere-forming potential: application of the limiting dilution analysis. J Mammary Gland Biol Neoplasia 17: 119-123.
25. Kripke ML, (1979) Speculations on the role of ultraviolet radiation in the development of malignant melanoma. J Natl Cancer Inst 63: 541-548.
26. Linnemann D, Raz A, Bock E, (1989) Differential expression of cell adhesion molecules in variants of K1735 melanoma cells differing in metastatic capacity. Int J Cancer 43: 709-712.
27. Fidler IJ, Gruys E, Cifone MA, Barnes Z, Bucana C, (1981) Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J Natl Cancer Inst 67: 947-956.
28. Talmadge JE, Fidler IJ, (1982) Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J Natl Cancer Inst 69: 975-980.
29. Shin SI, Freedman VH, Risser R, Pollack R, (1975) Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci U S A 72: 4435-4439.
30. Mueller-Klieser W, (1997) Three-dimensional cell cultures: from molecular mechanisms to clinical applications. Am J Physiol 273: C1109-1123.
31. Mueller-Klieser W, (2000) Tumor biology and experimental therapeutics. Crit Rev Oncol Hematol 36: 123-139.
32. Chen C, Wei Y, Hummel M, Hoffmann TK, Gross M, et al. (2011) Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One 6: e16466.
33. Zhong Y, Guan K, Guo S, Zhou C, Wang D, et al. (2010) Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells. Cancer Lett 299: 150-160.
34. Feng D, Peng C, Li C, Zhou Y, Li M, et al. (2009) Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri. Oncol Rep 22: 1129-1134.
35. Hu Y, Smyth GK, (2009) ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 347: 70-78.
36. Bull ND, Bartlett PF, (2005) The adult mouse hippocampal progenitor is neurogenic but not a stem cell. J Neurosci 25: 10815-10821.
37. Kim RJ, Kim SR, Roh KJ, Park SB, Park JR, et al. (2010) Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer. Cancer Lett 287: 172-181.
38. Steponkiene S, Kavaliauskiene S, Purviniene R, Rotomskis R, Juzenas P, (2011) Quantum dots affect expression of CD133 surface antigen in melanoma cells. Int J Nanomedicine 6: 2437-2444.
39. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, et al. (2010) Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466: 133-137.
40. Girouard SD, Laga AC, Mihm MC, Scolyer RA, Thompson JF, et al. (2012) SOX2 contributes to melanoma cell invasion. Lab Invest.
41. Dou J, Wen P, Hu W, Li Y, Wu Y, et al. (2009) Identifying tumor stem-like cells in mouse melanoma cell lines by analyzing the characteristics of side population cells. Cell Biol Int 33: 807-815.
42. Held MA, Curley DP, Dankort D, McMahon M, Muthusamy V, et al. (2010) Characterization of melanoma cells capable of propagating tumors from a single cell. Cancer Res 70: 388-397.
43. Strizzi L, Abbott DE, Salomon DS, Hendrix MJ, (2008) Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma. Cell Cycle 7: 1931-1935.
44. Saalbach A, Hildebrandt G, Haustein UF, Anderegg U, (2002) The Thy-1/Thy-1 ligand interaction is involved in binding of melanoma cells to activated Thy-1- positive microvascular endothelial cells. Microvasc Res 64: 86-93.
45. Shanesmith RP, Smart C, Cassarino DS, (2011) Tissue microarray analysis of ezrin, KBA.62, CD166, nestin, and p-Akt in melanoma versus banal and atypical nevi, and nonmelanocytic lesions. Am J Dermatopathol 33: 663-668.
46. Stecca B, Mas C, Clement V, Zbinden M, Correa R, et al. (2007) Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc Natl Acad Sci U S A 104: 5895-5900.
47. Ramgolam K, Lauriol J, Lalou C, Lauden L, Michel L, et al. (2011) Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function. PLoS One 6: e18784.
48. Gedye C, Quirk J, Browning J, Svobodova S, John T, et al. (2009) Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells. Cancer Immunol Immunother 58: 1635-1646.
49. Uhr JW, Pantel K, (2011) Controversies in clinical cancer dormancy. Proc Natl Acad Sci U S A 108: 12396-12400.
50. Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, et al. (2010) Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18: 510-523.
51. Schatton T, Frank MH, (2009) Antitumor immunity and cancer stem cells. Ann N Y Acad Sci 1176: 154-169.